Atlas Trials

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Clinical trial NCT04970667 · COMPLETED

Trial details

NCT number
NCT04970667
Sponsor
Peking University Third Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Emotional DisorderNeurologic Disorder
Start date
2018-01-01
Primary completion
2020-01-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.